Found: 25
Select item for more details and to access through your institution.
Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating ox-LDL Pathways.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 13, p. 7193, doi. 10.3390/ijms22137193
- By:
- Publication type:
- Article
The Interplay between Angiopoietin-Like Proteins and Adipose Tissue: Another Piece of the Relationship between Adiposopathy and Cardiometabolic Diseases?
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 2, p. 742, doi. 10.3390/ijms22020742
- By:
- Publication type:
- Article
Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese Children.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 18, p. 4444, doi. 10.3390/ijms20184444
- By:
- Publication type:
- Article
Lipid-Lowering Therapy in Patients with Coronary Heart Disease and Prior Stroke: Mission Impossible?
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 4, p. 886, doi. 10.3390/jcm10040886
- By:
- Publication type:
- Article
Effectiveness of clinical scores in predicting coronary artery disease in familial hypercholesterolemia: a coronary computed tomography angiography study.
- Published in:
- La Radiologia Medica, 2023, v. 128, n. 4, p. 445, doi. 10.1007/s11547-023-01610-z
- By:
- Publication type:
- Article
How ANGPTL3 Inhibition Will Help Our Clinical Practice?
- Published in:
- Current Atherosclerosis Reports, 2023, v. 25, n. 1, p. 19, doi. 10.1007/s11883-022-01076-w
- By:
- Publication type:
- Article
Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS).
- Published in:
- Current Atherosclerosis Reports, 2021, v. 23, n. 11, p. 1, doi. 10.1007/s11883-021-00967-8
- By:
- Publication type:
- Article
Familial Chylomicronemia Syndrome (FCS): Recent Data on Diagnosis and Treatment.
- Published in:
- Current Atherosclerosis Reports, 2020, v. 22, n. 11, p. N.PAG, doi. 10.1007/s11883-020-00885-1
- By:
- Publication type:
- Article
The Fibrinogen-like Domain of ANGPTL3 Facilitates Lipolysis in 3T3-L1 Cells by Activating the Intracellular Erk Pathway.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 4, p. 585, doi. 10.3390/biom12040585
- By:
- Publication type:
- Article
Statin liver safety in non‐alcoholic fatty liver disease: A systematic review and metanalysis.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 2, p. 441, doi. 10.1111/bcp.14943
- By:
- Publication type:
- Article
Long‐term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 413, doi. 10.1111/liv.15497
- By:
- Publication type:
- Article
Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non‐alcoholic fatty liver disease.
- Published in:
- Liver International, 2019, v. 39, n. 12, p. 2301, doi. 10.1111/liv.14206
- By:
- Publication type:
- Article
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The role of lipid metabolism in shaping the expansion and the function of regulatory T cells.
- Published in:
- Clinical & Experimental Immunology, 2022, v. 208, n. 2, p. 181, doi. 10.1093/cei/uxab033
- By:
- Publication type:
- Article
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry.
- Published in:
- European Journal of Preventive Cardiology, 2024, v. 31, n. 8, p. 1038, doi. 10.1093/eurjpc/zwae036
- By:
- Publication type:
- Article
Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study.
- Published in:
- European Journal of Preventive Cardiology, 2022, v. 29, n. 5, p. 832, doi. 10.1093/eurjpc/zwab229
- By:
- Publication type:
- Article
Real-World Effectiveness of PCSK9 Inhibitors in Reducing LDL-C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries.
- Published in:
- Journal of the American Heart Association, 2023, v. 12, n. 21, p. 1, doi. 10.1161/JAHA.122.026550
- By:
- Publication type:
- Article
Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Association of Hypertriglyceridemia with All-Cause Mortality and Atherosclerotic Cardiovascular Events in a Low-Risk Italian Population: The TG-REAL Retrospective Cohort Analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
High TG to HDL ratio plays a significant role on atherosclerosis extension in prediabetes and newly diagnosed type 2 diabetes subjects.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Metabolic Syndrome but Not Fatty Liver-Associated Genetic Variants Correlates with Glomerular Renal Function Decline in Patients with Non-Alcoholic Fatty Liver Disease.
- Published in:
- Biomedicines, 2022, v. 10, n. 3, p. 720, doi. 10.3390/biomedicines10030720
- By:
- Publication type:
- Article
HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD).
- Published in:
- Biomedicines, 2020, v. 8, n. 12, p. 625, doi. 10.3390/biomedicines8120625
- By:
- Publication type:
- Article
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study.
- Published in:
- Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.937750
- By:
- Publication type:
- Article
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study.
- Published in:
- Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.937750
- By:
- Publication type:
- Article
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy.
- Published in:
- 2017
- By:
- Publication type:
- journal article